Neural Analytics is developing portable transcranial Doppler ultrasound devices that it expects could be used by first responders and emergency room physicians to accurately assess mild to severe traumatic brain injury, including concussions.
Researchers at UCLA's California NanoSystems Institute have developed a nanoparticle delivery system that improves an antibiotic's ability to combat the bacteria Francisella tularensis.
Diagnostic assays that usually require a desktop reader that costs several thousand dollars can now be done using a 3-D printed plate that attaches to a smartphone. Even better, the accuracy of the results achieved are comparable to standard laboratory equipment.
Olympus was slapped with another lawsuit over devices implicated in a superbug outbreak at UCLA Medical Center, adding to the company's mounting heap of litigation as it faces pushback from affected patients and families.
The U.S. Department of Justice subpoenaed Olympus Medical Systems in the latest portion of the long-unfurling saga of how and why duodenoscopes routinely used in colonoscopies and upper gastrointestinal tract examinations have continued to be a problematic source for the spread of deadly bacteria for years.
A group of UCLA researchers has come up with a new method designed to deliver nanoparticles, enzymes, antibodies, bacteria and other "large-sized" cargo into mammalian cells at the rate of 100,000 cells per minute--way faster than any of the other methods now in use.
Researchers at UCLA have developed a new method for the delivery of large molecules into cells. The tool has shown in early tests that it can shuttle nanoparticles, enzymes, antibodies, bacteria and other materials into cells at up to 100,000 cells per minute.
Less than a week after the FDA warned healthcare providers that endoscopes' design could make them more difficult to clean, contributing to the spread of drug-resistant bacteria, Olympus is facing the first patient suit over the devices stemming from a "superbug" outbreak at the UCLA Health System in California.
The U.S. Food and Drug Administration is working to update the labels for duodenoscopes linked to the recent "superbug" outbreak that were inadequately cleaned, according to a Reuters report.
Investigators at the University of California, Los Angeles, have found that a drug being studied for a rare genetic disorder called Gaucher disease also appears to slow the progression of Parkinson's disease in mice.